Core Viewpoint - A securities class action lawsuit has been filed against SelectQuote, Inc. for failing to disclose material information, with a deadline for lead plaintiff applications set for October 10, 2025 [1][3]. Group 1: Lawsuit Details - The lawsuit involves SelectQuote and certain executives, alleging violations of federal securities laws during the class period from September 9, 2020, to May 1, 2025 [1][3]. - The U.S. Department of Justice filed a complaint against SelectQuote on May 1, 2025, claiming the company received "tens of millions of dollars" in illegal kickbacks from health insurance companies from 2016 to at least 2021 [4]. - The DOJ alleges that SelectQuote engaged in a conspiracy to discriminate against less profitable Medicare beneficiaries and made materially false claims about offering unbiased coverage comparisons [4]. Group 2: Financial Impact - Following the DOJ's allegations, SelectQuote's share price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, amid unusually heavy trading volume [4]. Group 3: Legal Representation - Kahn Swick & Foti, LLC, a prominent securities litigation law firm, is representing investors in this case, with a strong track record in recovering investment losses due to corporate fraud [5].

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. for misleading statements and illegal practices related to Medicare insurance plans during the Class Period from September 9, 2020, to May 1, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit alleges that SelectQuote directed Medicare beneficiaries to plans that compensated the company rather than providing unbiased comparisons [5]. - It claims that SelectQuote received illegal kickbacks to steer beneficiaries towards certain insurers, violating applicable laws and regulations [5]. - The lawsuit asserts that the positive statements made by SelectQuote regarding its business were materially misleading and lacked a reasonable basis [5]. Group 2: Class Action Participation - Investors who purchased SelectQuote securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by submitting a form or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by October 10, 2025, to represent the class in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions for investors [4].

Core Viewpoint - Wall Street anticipates flat earnings for SelectQuote (SLQT) compared to the previous year, with expectations of higher revenues impacting stock price movements based on actual results [1][2]. Earnings Expectations - The upcoming earnings report is expected on August 21, with a consensus estimate of a quarterly loss of $0.18 per share, unchanged from the year-ago quarter [3]. - Revenues are projected to be $333.42 million, reflecting an 8.5% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has remained stable over the last 30 days, indicating no significant changes in analysts' outlooks [4]. - The Most Accurate Estimate for SelectQuote is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -25.71%, suggesting a bearish sentiment among analysts [11]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive reading is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank of 1, 2, or 3 [9]. - SelectQuote currently holds a Zacks Rank of 3, making it challenging to predict an earnings beat conclusively [11]. Historical Performance - In the last reported quarter, SelectQuote was expected to post earnings of $0.04 per share but delivered only $0.03, resulting in a surprise of -25.00% [12]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [13]. Conclusion - SelectQuote does not appear to be a strong candidate for an earnings beat, and investors should consider other factors when making decisions regarding the stock ahead of the earnings release [16].

On this news, SelectQuote's stock price fell $0.61, or 19.2%, to close at $2.56 per share on May 1, 2025, on unusually heavy trading volume. Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In SelectQuote To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in SelectQuote between September 9, 2020 and May 1, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh ...

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. for alleged violations of securities laws, specifically related to misleading statements made by the company regarding its business practices in Medicare services [1][4]. Group 1: Lawsuit Details - The lawsuit is based on claims that SelectQuote made false and misleading statements to the market, particularly regarding its practices of directing Medicare beneficiaries to plans that provided the highest payments to the company, rather than considering the suitability of those plans for customers [4]. - The class period for the lawsuit is defined as from September 9, 2020, to May 1, 2025, during which investors who purchased the company's securities may have suffered losses [2]. Group 2: Investor Participation - Investors who believe they have incurred losses due to SelectQuote's actions are encouraged to contact the Schall Law Firm before October 10, 2025, to discuss their rights and potentially participate in the class action [2][3]. - The class has not yet been certified, meaning that until certification occurs, affected investors are not represented by an attorney [3]. Group 3: Allegations Against the Company - The complaint alleges that SelectQuote received kickbacks for steering Medicare customers to specific insurers while limiting enrollment options for competitors, which contributed to the misleading nature of the company's public statements [4]. - The misleading statements resulted in significant damages to investors once the truth about SelectQuote's practices became public [4].

Core Viewpoint - SelectQuote, Inc. is facing a securities class action lawsuit for failing to disclose material information during the class period from September 9, 2020, to May 1, 2025, which has implications for investors who purchased the company's securities during this time [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the United States District Court for the Southern District of New York, with a deadline for lead plaintiff applications set for October 10, 2025 [1]. - The case is titled Pahlkotter v. SelectQuote, Inc., et al., No. 25-cv-06620 [5]. - The U.S. Department of Justice filed a False Claims Act complaint against SelectQuote, alleging the company received "tens of millions of dollars" in illegal kickbacks from health insurance companies from 2016 to at least 2021 [4]. Group 2: Allegations Against SelectQuote - The DOJ claims that SelectQuote engaged in a conspiracy with major insurers to illegally discriminate against less profitable beneficiaries, including those with disabilities [4]. - The company allegedly misrepresented its services by claiming to offer "unbiased coverage comparisons," while directing Medicare beneficiaries to plans that provided the highest kickbacks [4]. - Following the DOJ's allegations, SelectQuote's share price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, amid heavy trading volume [4]. Group 3: Investor Resources - ClaimsFiler provides a free service for investors to access information regarding securities class action settlements and encourages affected investors to register for updates [6]. - Investors can upload their portfolio transactional data to receive notifications about relevant securities cases [6]. - Legal assistance is available through Kahn Swick & Foti, LLC for those seeking to understand their options regarding the lawsuit [2].

NEW YORK, Aug. 13, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of SelectQuote, Inc. (NYSE: SLQT) between September 9, 2020 and May 1, 2025. If you wish to serve as lead plaintiff, you must move the Court no later than October 10, 2025.So what: If you purchased SelectQuote securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or cos ...

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. for alleged violations of federal securities laws, impacting investors who purchased the company's securities between September 9, 2020, and May 1, 2025 [1][2]. Summary by Sections Class Definition - The lawsuit aims to recover damages for all individuals and entities that acquired SelectQuote securities during the specified Class Period [2]. Case Details - The complaint alleges that SelectQuote's executives made materially false and misleading statements and failed to disclose significant adverse facts about the company's operations, including: 1. Directing Medicare beneficiaries to plans that compensated SelectQuote rather than providing unbiased comparisons [3]. 2. Receiving illegal kickbacks to steer beneficiaries to certain insurers [3]. 3. Non-compliance with applicable laws and regulations, making the company vulnerable to legal sanctions [3]. 4. Misleading positive statements regarding the company's business and prospects [3]. Stock Price Impact - Following the news of the lawsuit, SelectQuote's stock price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually high trading volume [4]. Next Steps - Investors who suffered losses in SelectQuote have until October 10, 2025, to request appointment as lead plaintiff in the class action [5]. Legal Representation - The law firm Bronstein, Gewirtz & Grossman operates on a contingency fee basis, meaning they will only collect fees if the case is successful [6][7].

Hagens Berman urges SelectQuote investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys. Class Period: Sept. 9, 2020 – May 1, 2025 Lead Plaintiff Deadline: Oct. 10, 2025 Visit: www.hbsslaw.com/investor-fraud/slqt Contact the Firm Now: [email protected] 844-916-0895 SAN FRANCISCO, Aug. 13, 2025 /PRNewswire/ -- After investors in SelectQuote (NYSE: SLQT) saw the price of their s ...

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. due to allegations of receiving illegal kickbacks from health insurance companies and misleading Medicare beneficiaries [1][3][4]. Group 1: Legal Allegations - The U.S. Department of Justice filed a complaint against SelectQuote, alleging that from 2016 to at least 2021, the company received "tens of millions of dollars" in illegal kickbacks for steering Medicare beneficiaries to specific insurance plans [3]. - The complaint claims that SelectQuote made materially false statements regarding its services, asserting it provided unbiased coverage comparisons while actually directing beneficiaries to the most profitable plans for the company [4]. - SelectQuote is accused of failing to disclose significant adverse facts about its business practices, including directing beneficiaries to plans based on compensation rather than quality [4]. Group 2: Financial Impact - Following the DOJ's announcement, SelectQuote's stock price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually high trading volume [3]. Group 3: Investor Actions - Investors who purchased SelectQuote securities between September 9, 2020, and May 1, 2025, are encouraged to contact Bragar Eagel & Squire for potential legal recourse [1][5]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 10, 2025 [1].